Key Takeaways
- There is no industry-wide consensus on what constitutes a measurable outcome in substance use disorder treatment. Different payers use different definitions, creating a moving target for operators trying to build measurement infrastructure.
- Longitudinal patient tracking after discharge remains an unsolved problem at scale. Unlike procedure-based medicine, behavioral health outcomes unfold over months and years, shaped by variables that extend well beyond the treatment episode.
- Self-reported outcomes data will not satisfy sophisticated payers. Third-party validated measurement tools carry significantly more weight in contract negotiations than proprietary, internally compiled figures.
- Operators with verified outcomes data can use it as negotiating leverage. One SUD operator secured a 20% mid-contract rate increase by demonstrating, with externally validated numbers, that its patients achieved better sobriety outcomes at lower total cost.
- AI-driven relapse prediction tools are an emerging application of outcomes infrastructure, enabling proactive outreach to at-risk alumni before a crisis occurs rather than after.
- The operators building credible measurement systems now, even with imperfect tools, will be better positioned as payer demands tighten and acquirers weight outcomes data more heavily in valuations.
Somewhere between what behavioral health operators know about their patients and what they can prove to payers, there is a gap. It surfaced repeatedly during a panel at the 2026 Behavioral Health Summit for Executives (BHASe) in Miami this February, where four executives discussed technology adoption and sustainable growth during a session on “Bridging Gaps with Tech: A Roadmap for Sustainable Growth in Behavioral Health.”
The panelists shared concrete examples of technology driving efficiency, integrating data, and strengthening payer relationships. But when the conversation turned to outcomes measurement, the tone shifted. This was the area where even the most sophisticated operators acknowledged they are still improvising.
The demand side is clear enough. Payers invoke “value-based outcomes” with growing frequency. Regulators want data. Private equity acquirers want evidence that programs produce measurable results. Everyone agrees, at least in principle, that treatment centers should be able to demonstrate that what they do works. The supply side is where things break down.
The Behavioral Health Outcomes Measurement Problem: No Standard Definition
Start with the most basic question: what counts as an outcome in substance use disorder treatment? Sobriety at 30 days? At 90? Reduction in emergency department utilization? Sustained employment? Treatment completion? The answer changes depending on who is asking. One payer may define value in terms of readmission rates. Another may care about length of sobriety post-discharge. A third may use a composite metric that no one else in the industry recognizes.
For operators, this inconsistency creates a moving target. Building an outcomes measurement system for one payer’s definition does not necessarily satisfy another’s. And investing in outcomes infrastructure without knowing which metrics will matter most in the next contract negotiation can feel like buying equipment for a sport whose rules have not been finalized. The challenge is compounded by the fact that payers are actively tightening their definitions of value as value-based care contracts move from aspiration to operational reality.
Why Behavioral Health Data Infrastructure Lags Behind Other Healthcare Sectors
Even where the metrics are agreed upon, the tools to collect and report them reliably remain underdeveloped relative to the rest of healthcare. There is no broadly adopted, third-party platform that compiles longitudinal patient data across behavioral health providers, enabling apples-to-apples outcome comparisons. In substance use treatment, where relapse is common and patients frequently cycle through multiple facilities over the course of years, tracking what happens after discharge is an unsolved problem at scale. The broader data visibility gap that plagues SUD and ABA operators runs deeper than outcomes measurement alone: most facilities cannot easily surface even basic operational metrics across their existing software systems.
This is fundamentally different from procedure-based medicine. A knee replacement either restored function or it did not. Behavioral health outcomes unfold over months and years, are shaped by variables that extend far beyond any single provider’s control, and depend on patients who may or may not stay in contact after they leave care.
Self-Reported vs. Third-Party Validated Outcomes Data: What Payers Will Accept
At the BHASe panel, two operators described different approaches to this challenge, both of which illustrate the current state of the field.
DJ Prince, Chief Strategy Officer at Guardian Recovery, described building outcomes tracking directly into Salesforce. Guardian captures alumni feedback, survey data, and outreach call results through the platform and has layered Salesforce’s AI capabilities on top to generate readmission risk scores. Those scores drive a prioritized call list for outbound agents, who focus their outreach on alumni with the highest probability of relapse. The system is functional and has produced tangible results, including what Prince described as earlier interventions that may have prevented relapses or worse. But it is a proprietary build, not an industry standard, and it measures what Guardian can observe rather than what a payer would necessarily accept as independently validated. (For a broader look at the readiness requirements that separate effective behavioral health tech adoption from expensive mistakes, Acuity has covered that terrain separately.)
Drew LaBoon, COO of Pathways Recovery Centers, has taken a different route. Pathways uses third-party outcome measurement tools like Care Predictor, and LaBoon was emphatic about why: payers do not want to see outcomes data compiled by the organization whose performance it is supposed to evaluate. Self-reported data, however honestly collected, lacks the credibility that comes with independent validation. A spreadsheet assembled in-house will not carry the same weight as data from a tool designed for the purpose and operated by a neutral party.
How Validated Outcomes Data Can Unlock Mid-Contract Rate Increases
The practical stakes became concrete when LaBoon described using validated outcomes data to negotiate a 20% mid-contract rate increase with payers. The argument succeeded because Pathways could demonstrate, with externally verified numbers, that its patients achieved better sobriety outcomes, which reduced the payer’s total cost over time. That negotiation is not possible with self-reported data. The payer has no reason to accept it at face value.
The connection between outcomes infrastructure and valuation runs in both directions. Private equity acquirers in behavioral health are increasingly weighting outcomes data in their diligence processes, and the KPIs that drive strong behavioral health valuations now extend well beyond financial metrics. Organizations that can demonstrate verified clinical performance have a meaningful negotiating advantage, whether the counterparty is a payer or a buyer.
Prince described a parallel dynamic from the clinical side. Guardian’s Salesforce-based system had identified alumni at elevated relapse risk, enabling proactive outreach. In the fentanyl era, the clinical stakes of that capability are difficult to overstate. “One more day for that client out there using because we didn’t appropriately predict their potential relapse is a missed opportunity to help them,” Prince said.
Where Behavioral Health Outcomes Measurement Is Headed
The behavioral health industry is moving, unevenly and sometimes reluctantly, toward a world where outcomes measurement is a baseline expectation rather than a differentiator. Payer demands are tightening. Regulatory scrutiny is increasing. Acquirers are weighting outcomes data more heavily in their valuations. Recent investment activity reflects this: Honest Health’s $140 million raise was predicated on building the infrastructure to make value-based care contracts operational at scale, a goal that is impossible without credible outcomes data on both sides of the agreement.
The long road to value-based care in behavioral health has always run through outcomes measurement. The difference now is that the consequences of not having that infrastructure are beginning to show up in contract negotiations and acquisition conversations.
The organizations investing in credible, validated measurement infrastructure now, even when the tools are imperfect and the definitions are still shifting, are positioning themselves for that future. The operators waiting for the industry to agree on standards before they begin building may find that the standards arrive and they have nothing to report.
That tension between the urgency of the demand and the immaturity of the tools was palpable during the BHASe panel. None of the executives on stage claimed to have fully solved the outcomes problem. What they had was a clear-eyed understanding of its importance and a willingness to build imperfect systems rather than wait for perfect ones. In an industry where the human cost of inaction is measured in relapses and overdoses, that willingness may be the most important technology of all.
Frequently Asked Questions:
What is behavioral health outcomes measurement?
Behavioral health outcomes measurement refers to the systematic collection and reporting of data that demonstrates whether treatment produced meaningful clinical results. In substance use disorder treatment, common metrics include sobriety duration, readmission rates, emergency department utilization, treatment completion, and sustained employment. The challenge is that different payers, regulators, and acquirers use different definitions, and no single industry-wide standard currently exists.
Why do payers require third-party validated outcomes data?
Payers are skeptical of self-reported outcomes data because the organization producing it has a financial interest in the results. Third-party validated tools, such as Care Predictor and similar platforms, are operated independently and follow standardized methodologies, giving payers confidence that the numbers reflect actual patient performance rather than selective reporting. Self-reported data, however honestly compiled, is unlikely to be accepted in value-based contract negotiations or payer audits.
How can behavioral health operators use outcomes data to negotiate better payer rates?
Operators with externally validated outcomes data can use it to demonstrate that their programs reduce payers’s total cost of care over time, principally by lowering readmission rates and emergency utilization. This creates a business case for higher reimbursement rates that does not rest on volume alone. As described at the 2026 BHASe panel, one SUD operator secured a 20% mid-contract rate increase on exactly this basis. The prerequisite is data that the payer will accept as credible, which requires independent validation. For a broader framework on what payers and acquirers look for in behavioral health KPIs, the underlying logic is similar.
What role does AI play in behavioral health outcomes tracking?
AI applications in outcomes tracking are emerging primarily in two areas: predictive risk scoring (identifying patients most likely to relapse or disengage after discharge, enabling proactive outreach) and pattern recognition across large alumni datasets (surfacing which treatment characteristics correlate with better long-term outcomes). These tools are most valuable when built on clean, consistent underlying data. Organizations with fragmented or poorly structured patient records will find that AI amplifies their data problems rather than solving them.
What is value-based care in behavioral health, and why does outcomes measurement matter for it?
Value-based care (VBC) refers to payment models that tie reimbursement, at least in part, to patient outcomes rather than volume of services delivered. In behavioral health, VBC contracts can include shared savings arrangements, bundled payments, and capitation. Outcomes measurement is the foundation of any VBC model: without reliable data on what a program actually achieves, neither the provider nor the payer can assess whether the arrangement is working. CMS has set a target for the majority of payments to be in value-linked models by 2030, and commercial payers are already moving in that direction. For more on the operational realities of value-based care in mental health and SUD, Acuity has covered that space in depth.
How does the behavioral health outcomes infrastructure gap affect M&A valuations?
Private equity acquirers increasingly treat outcomes data as a diligence requirement rather than a bonus. Organizations that can demonstrate verified clinical performance, with independently validated metrics rather than internal spreadsheets, tend to command stronger multiples and face fewer valuation adjustments during diligence. Conversely, operators without credible outcomes infrastructure may face questions about program efficacy that are difficult to answer under diligence timelines. The KPIs that drive behavioral health valuations now extend well beyond EBITDA and census, and private equity’s appetite for behavioral health investment is increasingly tied to the ability to demonstrate that clinical programs produce measurable results.
